Karl P. Flora
- Molecular Biology
- Infectious Diseases top 10%
- Oncology
- Virology top 5%
- Pharmacology top 10%
- Co-authors
- Lawrence A. TrisselJames C. CradockJonathan WilsonB. Rao VishnuvajjalaBarry R. GoldspielJonathan D. AdamsSusan G. ArbuckRichard W. Finley
- Topics
- Pharmaceutical studies and practices (7 papers)Cancer Treatment and Pharmacology (5 papers)Cancer therapeutics and mechanisms (5 papers)
- Partner nations
- United StatesMalaysiaNetherlands
In The Last Decade
Karl P. Flora
26 papers receiving 858 citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 251
- Infectious Diseases 209
- Oncology 195
- Virology 154
- Pharmacology 136
Countries citing papers authored by Karl P. Flora
This map shows the geographic impact of Karl P. Flora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl P. Flora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl P. Flora more than expected).
Fields of papers citing papers by Karl P. Flora
This network shows the impact of papers produced by Karl P. Flora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl P. Flora. The network helps show where Karl P. Flora may publish in the future.
Co-authorship network of co-authors of Karl P. Flora
This figure shows the co-authorship network connecting the top 25 collaborators of Karl P. Flora. A scholar is included among the top collaborators of Karl P. Flora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl P. Flora. Karl P. Flora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 28 | |
| 3 | 20 | |
| 4 | 17 | |
| 5 | 59 | |
| 6 | Taxol: a history of pharmaceutical development and current pharmaceutical concerns. | 136 |
| 7 | 45 | |
| 8 | 12 | |
| 9 | 12 | |
| 10 | 37 | |
| 11 | 127 | |
| 12 | 71 | |
| 13 | 23 | |
| 14 | 12 | |
| 15 | 6 | |
| 16 | 15 | |
| 17 | 10 | |
| 18 | 11 | |
| 19 | 5 | |
| 20 | Stability of anthracycline antitumor agents in four infusion fluids. | 25 |
About Karl P. Flora
Karl P. Flora is a scholar working on Toxicology, Occupational Therapy and Geriatrics and Gerontology, having authored 26 papers that have together received 897 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (7 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Virology (154 citations), Occupational Therapy (49 citations) and Infectious Diseases (209 citations). Karl P. Flora has collaborated with scholars based in United States, Malaysia and Netherlands. Frequent co-authors include Lawrence A. Trissel, James C. Cradock, Jonathan Wilson, B. Rao Vishnuvajjala, Barry R. Goldspiel, Jonathan D. Adams, Susan G. Arbuck, Richard W. Finley, Hiroaki Mitsuya and David G. Johns. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, British Journal of Cancer and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.